[Federal Register Volume 71, Number 129 (Thursday, July 6, 2006)]
[Notices]
[Pages 38406-38407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-5990]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Training in Computational Neuroscience: From Biology 
to Model and Back Again.
     Date: June 29, 2006.
     Time: 8:30 a.m. to 5 a.m.
     Agenda: To review and evaluate grant applications.
     Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
     Contact Person: Murat Oz, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Neuroscience Center, Rm. 229, MSC 8401, 6101 Executive 
Boulevard, Bethesda, MD 20892, 301-435-1433, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Member Conflict.
    Date: June 30, 2006.
    Time: 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401, 301-402-6626, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Member Conflict.
     Date: July 18, 2006.
     Time: 5 p.m. to 7 p.m.
     Agenda: To review and evaluate grant applications.
     Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
     Contact Person: Murat Oz, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, Neuroscience Center, Rm. 229, MSC 8401, 6101 Executive 
Boulevard, Bethesda, MD 20892, 301-435-1433, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)



[[Page 38407]]


    Dated: June 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5990 Filed 7-5-06; 8:45 am]
BILLING CODE 4140-01-M